SCHEMBL7027927

SCHEMBL7027927

[Cu].c1ccc([PH2](c2ccccc2)c2ccccc2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.38
▸ MAOB P27338 1/20 0.35
▸ TSHR P16473 5/20 0.33
▸ TDP1 Q9NUW8 5/20 0.33
▸ CA1 P00915 2/20 0.33
▸ CA2 P00918 2/20 0.33
▸ CA9 Q16790 2/20 0.33
▸ ALOX12 P18054 2/20 0.33
▸ CA12 O43570 1/20 0.33
▸ GLA P06280 1/20 0.33
▸ CA3 P07451 1/20 0.33
▸ CA4 P22748 1/20 0.33
▸ CA14 Q9ULX7 1/20 0.33
▸ LMNA P02545 1/20 0.33
▸ ACHE P22303 1/20 0.33
▸ CA7 P43166 1/20 0.33
▸ HSD17B10 Q99714 3/20 0.32
▸ CYP3A4 P08684 2/20 0.32
▸ MAPT P10636 2/20 0.32
▸ POLB P06746 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1679860 0.96 ALDH1A1 (0.40) ALDH1A1TSHRTDP1CA1CA2
SCHEMBL2809108 0.92 ALDH1A1 (0.38) ALDH1A1TSHRTDP1CA1CA2
Hydrochloric Acid SCHEMBL29742149 0.92 ALDH1A1 (0.38) ALDH1A1TSHRTDP1CA1CA2
Ammonia Solution, Strong SCHEMBL10353912 0.92 ALDH1A1 (0.38) ALDH1A1TSHRTDP1CA1CA2
SCHEMBL11851387 0.92 ALDH1A1 (0.38) ALDH1A1TSHRTDP1CA1CA2
SCHEMBL10560031 0.92 ALDH1A1 (0.38) ALDH1A1TSHRTDP1CA1CA2
Hydrochloric Acid SCHEMBL29391525 0.89 ALDH1A1 (0.35) ALDH1A1TSHRTDP1CA1CA2
Ethyne SCHEMBL2390599 0.89 ALDH1A1 (0.35) ALDH1A1TSHRTDP1CA1CA2
Ethylene SCHEMBL6059829 0.89 ALDH1A1 (0.35) ALDH1A1TSHRTDP1CA1CA2
Ammonia Solution, Strong SCHEMBL31046202 0.81 BBOX1 (0.32) ALDH1A1BBOX1EHMT2EHMT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110143889-B Synthetic method of 3- [ (dimethylamino) methyl ] -5-methyl-2-hexanone 江苏暨明医药科技有限公司 2022-04-12 — — CN claimed
EP-0677074-B1 COPPER HYDRIDES AS CO-CATALYSTS FOR CYCLIC OLEFIN POLYMERIZATION SHELL OIL CO (US) 1997-04-16 — — EP claimed
EP-0677074-A1 COPPER HYDRIDES AS CO-CATALYSTS FOR OLEFIN POLYMERIZATION. SHELL OIL CO (US) 1995-10-18 — — EP claimed
WO-1994015988-A1 COPPER HYDRIDES AS CO-CATALYSTS FOR OLEFIN POLYMERIZATION SHELL OIL COMPANY (US) 1994-07-21 — — WO claimed
US-5316994-A Copper hydrides as co-catalysts for olefin polymerization SHELL OIL COMPANY (US) 1994-05-31 — — US claimed
CN-111164092-B Process for producing peptide compound 日产化学株式会社 2023-12-26 — — CN disclosed
CN-110143889-B Synthetic method of 3- [ (dimethylamino) methyl ] -5-methyl-2-hexanone 江苏暨明医药科技有限公司 2022-04-12 — — CN disclosed
CN-110143889-B Synthetic method of 3- [ (dimethylamino) methyl ] -5-methyl-2-hexanone 江苏暨明医药科技有限公司 2022-04-12 — — CN disclosed
US-20200291061-A1 METHOD FOR PRODUCING PEPTIDE COMPOUND NISSAN CHEMICAL CORPORATION (JP) 2020-09-17 — — US disclosed
EP-3693377-A1 METHOD FOR PRODUCING PEPTIDE COMPOUND Nissan Chemical Corporation (JP) 2020-08-12 — — EP disclosed
CN-111164092-A Method for producing peptide compound 日产化学株式会社 2020-05-15 — — CN disclosed
EP-0789022-B1 Difluoroprostacyclins, intermediates for production thereof and processes for production thereof ASAHI GLASS CO LTD (JP) 2003-06-18 — — EP disclosed
US-5616732-A Intermediates for difluoroprostacyclins and methods for their production ASAHI GLASS COMPANY LTD. (JP) 1997-04-01 — — US disclosed
US-5538995-A Difluoroprostacyclins ASAHI GLASS COMPANY LTD. (JP) 1996-07-23 — — US disclosed
EP-0677074-A1 COPPER HYDRIDES AS CO-CATALYSTS FOR OLEFIN POLYMERIZATION. SHELL OIL CO (US) 1995-10-18 — — EP disclosed
EP-0669329-A1 Difluorprostacyclins, intermediates for production thereof and processes for production thereof ASAHI GLASS COMPANY LTD. (JP) 1995-08-30 — — EP disclosed
US-5405865-A Pyrethroid esters ROUSSEL-UCLAF (FR) 1995-04-11 — — US disclosed
US-5340835-A Insecticides ROUSSEL-UCLAF (FR) 1994-08-23 — — US disclosed
WO-1994015988-A1 COPPER HYDRIDES AS CO-CATALYSTS FOR OLEFIN POLYMERIZATION SHELL OIL COMPANY (US) 1994-07-21 — — WO disclosed
US-5316994-A Copper hydrides as co-catalysts for olefin polymerization SHELL OIL COMPANY (US) 1994-05-31 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200291061-A1 METHOD FOR PRODUCING PEPTIDE COMPOUND VIP, NGLY1, IAPP ALDH1A1 4659/4885MAOB 3213/4885TSHR 817/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback